NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc. Stock News
$27.27
+0.750 (+2.83%)
At Close: May 03, 2024
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
Baird likes drug wholesalers in premarket analyst action
12:58pm, Friday, 07'th Feb 2020
Arcturus Therapeutics (NASDAQ:ARCT) initiated with Buy rating and $19 (70% upside) price target at Guggenheim.BeyondSpring (NASDAQ:BYSI) initiated with Buy rating and $25 (45% upside) price target at
How Reginald Ruffin led Miles to Division II playoffs
03:50pm, Friday, 22'nd Nov 2019
The Golden Bears have won four Southern Intercollegiate Athletic Conference titles and twice earned a spot in the NCAA Division II playoffs during Ruffin’s tenure.
A Base Editing IPO from Beam Therapeutics
05:59am, Tuesday, 01'st Oct 2019
The ability to modify genes may be one of the most promising disruptive technologies there is today. As the general public learns about the potential of gene editing, retail investors will be looki
De cursos no Senac ao ensino superior: Minas
10:01am, Tuesday, 07'th Aug 2018
Antes de o chef se tornar a estrela dos restaurantes e dos reality shows, Minas Gerais j
STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics -
03:56pm, Tuesday, 12'th Dec 2017
STORM Therapeutics Exclusive Speaker Interview
